Nuclear factor (NF)-κB2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses

Journal of Experimental Medicine

Volumn 187, Issue 2, 1998, Pages 185-196

  Caamaño, Jorge H ^a,c   Rizzo, Cheryl A ^a   Durham, Stephen K ^a   Barton, Debra S ^a   Raventós Suárez, Carmen ^a   Snapper, Clifford M ^b   Bravo, Rodrigo ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE MUTATION; GERMINAL CENTER; HISTOPATHOLOGY; HUMORAL IMMUNE DEFICIENCY; HUMORAL IMMUNITY; IMMUNOREACTIVITY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN;

ANIMALS; ANTIGENS, CD40; B-LYMPHOCYTE SUBSETS; BONE MARROW CELLS; EPITOPES; FEMALE; GERMINAL CENTER; IMMUNITY, CELLULAR; IMMUNOGLOBULINS; LIPOPOLYSACCHARIDES; LYMPH NODES; LYMPHOCYTE ACTIVATION; LYMPHOPENIA; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; MICE, KNOCKOUT; MUTAGENESIS, INSERTIONAL; NF-KAPPA B; NF-KAPPA B P52 SUBUNIT; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION; SPLEEN;

EID: 0031985287     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.2.185     Document Type: Article

References (75)

1. Schmid, R.M., N.D. Perkins, C.S. Duckett, P.C. Andrews, and G.J. Nabel. 1991. Cloning of an NF-κB subunit which stimulates HIV transcription in synergy with p65. Nature. 352:733-736.
2. Mercurio, F., J. Didonato, C. Rosette, and M. Karin. 1992. Molecular cloning and characterization of a novel Rel/NF-κB family member displaying structural and functional homology to NF-κB p50/p105. DNA Cell Biol. 11:523-537.
3. Bours, V., P.R. Burd, K. Brown, J. Villalobos, S. Park, R.-P. Ryseck, R. Bravo, K. Kelly, and U. Siebenlist. 1992. A novel mitogen-inducible gene product related to p50/p105-NF-κB participates in transactivation through a κB site. Mol. Cell. Biol. 12:685-695.
4. Neri, A., C.C. Chang, L. Lombardi, M. Salina, P. Corradini, A.T. Maiolo, R.S. Chaganti, and R. Dalla-Favera. 1991. B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-κB p50. Cell. 67: 1075-1087.
5. Migliazza, A., L. Lombardi, M. Rocchi, D. Trecca, C.-C. Chang, R. Antonacci, N.S. Fracchiolla, P. Ciana, A.T. Maiolo, and A. Neri. 1994. Heterogeneous chromosomal aberrations generate 3′ truncations of the NFKB2/lyt-10 gene in lymphoid malignancies. Blood. 84:3850-3860.
6. Thakur, S., H.-C. Lin, W.-T. Tseng, S. Kumar, R. Bravo, F. Foss, C. Gélinas, and A.B. Rabson. 1994. Rearrangement and altered expression of the NFKB-2 gene in human cutaneous T-lymphoma cells. Oncogene. 9:2335-2344.
7. Fracchiolla, N.S., L. Lombardi, M. Salina, A. Migliazza L. Baldini, E. Berti, L. Cro, E. Polli, A.T. Maiolo, and A. Neri. 1993. Structural alterations of the NF-κB transcription factor lyt-10 in lymphoid malignancies. Oncogene. 8:2839-2845.
8. Chang, C.-C., J. Zhang, L. Lombardi, A. Neri, and R. Dalla-Favera. 1995. Rearranged NFKB-2 genes in lymphoid neoplasms code for constitutively active nuclear transactivators. Mol. Cell. Biol. 15:5180-5187.
9. Finco, T.S., and A.S. Baldwin. 1995. Mechanistic aspects of NF-κB regulation: the emerging role of phosphorylation and proteolysis. Immunity. 3:263-272.
10. Kopp, E.B., and S. Ghosh. 1995. NF-κB and Rel proteins in innate immunity. Adv. Immunol. 58:1-27.
11. Miyamoto, S., and I.M. Verma. 1995. Rel/NF-κB story. Adv. Cancer Res. 66:255-292.
12. Thanos, D., and T. Maniatis. 1995. NF-κB: A lesson in family values. Cell. 80:529-532.
13. Baeuerle, P.A., and D. Baltimore. 1996. NF-κB: ten years after. Cell. 87:13-20.
14. Baldwin, A.S. 1996. The NFκB and Iκβ proteins, new discoveries and insights. Annu. Rev. Immunol. 14:649-681.
15. Ghosh, S., A.M. Gifford, L.R. Riviere, P. Tempst, G.P. Nolan, and D. Baltimore. 1990. Cloning of the p50 DNA binding subunit of NF-κB: homology to rel and dorsal. Cell. 62: 1019-1029.
16. Kieran, M., V. Blank, F. Logeat, J. Vandekerckhove, F. Lottspeich, O. LeBail, M.B. Urban, P. Kourilsky, P.A. Baeuerle, and A. Israel. 1990. The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product. Cell. 62:1007-1018.
17. Mercurio, F., J.A. DiDonato, C. Rosette, and M. Karin. 1993. p105 and p98 precursor proteins play an active role in NF-κB-mediated signal transduction. Genes Dev. 7:705-718.
18. Beg, A.A., W.C. Sha, R.T. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature. 376: 167-169.
19. Burkly, L., C. Hession, L. Ogata, C. Reilly, L.A. Marconi, D. Olson, R. Tizard, R. Cate, and D. Lo. 1995. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature. 373:531-536.
20. Köntgen, F., R.J. Grumont, A. Strasser, D. Metcalf, R. Li, D. Tarlinton, and S. Gerondakis. 1995. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9:1965-1977.
21. Sha, W.C., H.-C. Liou, E.I. Tuomanen, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell. 80:321-330.
22. Weih, F., D. Carrasco, S.K. Durham, D.S. Barton, C.A. Rizzo, R.-P. Ryseck, S.A. Lira, and R. Bravo. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/ Rel family. Cell. 80:331-340.
23. Brown, K., S. Gerstberger, L. Carlson, G. Franzoso, and U. Siebenlist. 1995. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation. Science. 267:1485-1488.
24. Thompson, J.E., R.J. Phillips, H. Erdjument-Bromage, P. Tempst, and S. Ghosh. 1995. IκB-β regulates the persistent response in a biphasic activation of NF-κB. Cell. 80:573-582.
25. Chen, Z.J., L. Parent, and T. Maniatis. 1996. Site-specific phosphorylation of the Iκ-Bα by a novel ubiquitination-dependent protein kinase activity. Cell. 84:853-862.
26. DiDonato, J., F. Mercurio, C. Rosette, J. Wu-Li, H. Suyang, S. Ghosh, and M. Karin. 1996. Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol. 16:1295-1304.
27. Beg, A.A., W.C. Sha, R.T. Bronson, and D. Baltimore. 1995. Constitutive NF-κB activation, enhanced granulopoiesis, and neonatal lethality in IκBα-deficient mice. Genes Dev. 9:2736-2746.
28. Klement, J.F., N.R. Rice, B.D. Car, S.J. Abbondanzo, G.D. Powers, H. Bhatt, C.-H. Chen, C.A. Rosen, and C.L. Stewart. 1996. IκBα deficiency results in a sustained NF-κB response and severe widespread dermatitis in mice. Mol. Cell. Biol. 16:2341-2349.
29. Franzoso, G., L. Carlson, T. Scharton-Kersten, E.W. Shores, S. Epstein, A. Grinberg, T. Tran, E. Shacter, A. Leonardi, M. Anver, et al. 1997. Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture and germinal center reactions. Immunity. 6:479-490.
30. Schwarz, E.M., P. Krimpenfort, A. Berns, and I.M. Verma. 1997. Immunological defects in mice with a targeted disruption in Bcl-3. Genes Dev. 11:187-197.
31. Gilmore, T.D., M. Koedood, K.A. Piffat, and D.W. White. 1996. Rel/NF-κB/IκB proteins and cancer. Oncogene. 13: 1367-1378.
32. Liou, H.-C., W.C. Sha, M.L. Scott, and D. Baltimore. 1994. Sequential induction of NF-κB/Rel family proteins during B-cell terminal differentiation. Mol. Cell. Biol. 14:5349-5359.
33. Grumont, R.J., and S. Gerondakis. 1994. The subunit composition of NF-κB complexes changes during B-cell development. Cell Growth Differ. 5:1321-1331.
34. Ohno, H., G. Takimoto, and T.W. McKeithan. 1990. The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control. Cell. 60: 991-997.
35. Bours, V., G. Franzoso, V. Azarenko, S. Park, T. Kannno, K. Brown, and U. Siebenlist. 1993. The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers. Cell. 72:729-739.
36. Fujita, T., G.P. Nolan, H.-C. Liou, M.L. Scott, and D. Baltimore. 1993. The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-κB p50 homodimers. Genes Dev. 7:1354-1363.
37. Caamaño, J.H., P. Perez, S.A. Lira, and R. Bravo. 1996. Constitutive expression of Bcl-3 in thymocytes increases the DNA binding of NF-κB (p50) homodimers in vivo. Mol. Cell. Biol. 16:1342-1348.
38. McBurney, M.W., L.C. Sutherland, C.N. Adra, B. Leclair, M.A. Rudnicki, and K. Jardine. 1991. The mouse Pgk-1 gene promoter contains an upstream activator sequence. Nucleic Acids Res. 20:5755-5761.
39. Tybulewicz, V.L.J., C.E. Crawford, P.K. Jackson, R.T. Bronson, and R.C. Mulligan. 1991. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell. 65:1153-1163.
40. Swiatek, P.J., and T. Gridley. 1993. Perinatal lethality and defects in hindbrain development in mice homozygous for a targeted mutation of the zinc finger gene Krox20. Genes Dev. 7:2071-2084.
41. Coligan, J.E., A.M. Kruisbeek, D.H. Margulies, E.M. Shevach, and W. Strober. 1992. Isolation and fractionation of mononuclear cell populations. In Current Protocols in Immunology. Greene Publishing Associates & Wiley-Interscience, John Wiley and Sons, New York. 3.0.1-3.1.5.
42. Snapper, C.M., F.R. Rosas, P. Zelazowski, M.A. Moorman, M.R. Kehry, R. Bravo, and F. Weih. 1996. B cells lacking RelB are defective in proliferative responses, but undergo normal B cell maturation to Ig secretion and Ig class switching. J. Exp. Med. 184:1537-1541.
43. Lernbecher, T., U. Müller, and T. Wirth. 1993. Distinct NF-κB/Rel transcription factors are responsible for tissue-specific and inducible gene activation. Nature. 365:767-770.
44. H transcription, and Ig class switching. J. Immunol. 156:183-191.
45. + B cells from antibody-secreting and memory B cell pathways in the C57BL/6 immune response to NP. Eur. J. Immunol. 22:3001-3011.
46. Snapper, C.M., and F.D. Finkelman. 1993. Immunoglobulin class switching. In Fundamental Immunology, 3 ed., W.E. Paul, editor. Raven Press, New York. pp. 837-863.
47. Snapper, C.M., and J.J. Mond. 1996. A model for induction of T cell-independent humoral immunity in response to polysaccharide antigens. J. Immunol. 157:2229-2223.
48. Stavnezer, J. 1996. Antibody class switching. Adv. Immunol. 61:79-147.
49. Weih, F., G. Warr, H. Yang, and R. Bravo. 1997. Multifocal defects in immune responses in RelB-deficient mice. J. Immunol. 158:5211-5218.
50. Kosco-Vilbois, M.H., and D. Scheidegger. 1995. Follicular dendritic cells: antigen retention, B cell activation, and cytokine production. Curr. Top. Microbiol. Immunol. 201:69-82.
51. Clark, E.A. 1997. Regulation of lymphocytes by dendritic cells. J. Exp. Med. 185:801-803.
52. Sen, R., and D. Baltimore. 1986. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell. 46:705-716.
53. Beg, A.A., and D. Baltimore. 1996. An essential role for NF-κB in preventing TNF-α-induced cell death. Science. 274:782-784.
54. Van Antwerp, D.J., S.J. Martin, T. Kafri, D.R. Green, and I.M. Verma. 1996. Suppression of TNF-α-induced apoptosis by NF-κB. Science. 274:787-789.
55. Wang, C.-Y., M.W. Mayo, and A.S. Baldwin, Jr. 1996. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science. 274:784-787.
56. Doi, T.S., T. Takahashi, O. Taguchi, T. Azuma, and Y. Obata. 1997. NF-κB RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses. J. Exp. Med. 185:953-961.
57. Weih, F., S.K. Durham, D.S. Barton, W.C. Sha, D. Baltimore, and R. Bravo. 1996. Both multiorgan inflammation and myeloid hyperplasia in RelB-deficient mice are T cell dependent. J. Immunol. 157:3974-3979.
58. Weih, F., D. Carrasco, and R. Bravo. 1994. Constitutive and inducible Rel/NF-κB activities in mouse thymus and spleen. Oncogene. 9:3289-3297.
59. Kelsoe, G. 1996. Life and death in germinal centers. Immunity. 4:107-111.
60. Liu, Y.-J., and J. Banchereau. 1996. Mutant mice without B lymphocyte follicles. J. Exp. Med. 184:1207-1211.
61. Liu, Y.-J., and J. Banchereau. 1996. The paths and molecular controls of peripheral B-cell development. The Immunologist. 4:55-66.
62. Rajewsky, K. 1996. Clonal selection and learning in the antibody system. Nature. 381:751-758.
63. Ahearn, J.M., M.B. Fischer, D. Croix, S. Georg, M. Ma, J. Zia, X. Zhou, R.G. Howard, T.L. Rothstein, and M.C. Carroll. 1996. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity. 4:251-262.
64. Förster, R., A.E. Mattis, E. Kremmer, E. Wolf, G. Brem, and M. Lipp. 1996. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell. 87:1037-1047.
65. Kawabe, T., T. Naka, K. Yoshida, T. Tanaka, H. Fujiwara, S. Suematsu, N. Yoshida, T. Kishimoto, and H. Kikutani. 1994. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity. 1:167-178.
66. Matsumoto, M., S. Mariathasan, M.H. Nahm, F. Baranyay, J.J. Peschon, and D.C. Chaplin. 1996. Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers. Science. 271:1289-1291.
67. Nielsen, P.J., O. Georgiev, B. Lorenz, and W. Schaffner. 1996. B lymphocytes are impaired in mice lacking the transcriptional co-activator Bob1/OCA-B/OBF1. Eur. J. Immunol. 26:3214-3218.
68. Renshaw, B.R., W.C.I. Fanslow, R.J. Armitage, K.A. Campbell, D. Liggitt, B. Wright, B.L. Davison, and C.R. Maliszewski. 1994. Humoral immune responses in CD40 ligand deficient mice. J. Exp. Med. 180:1889-1900.
69. Schubart, D.B., A. Rolink, M., Kosco-Vilbois, F. Botteri, and P. Matthias. 1996. B-cell-specific coactivator OBF-1/ OCS-B/Bob1 required for immune response and germinal centre formation. Nature. 383:538-542.
70. Xu, J., T.M. Foy, J.D. Laman, E.A. Elliott, J.J. Dunn, T.J. Waldschmidt, J. Elsemore, R.J. Noelle, and R.A. Flavell. 1994. Mice deficient for the CD40 ligand. Immunity. 1:423-431.
71. Kim, U., X.-F. Qin, S. Gong, S. Stevens, Y. Luo, M. Nussenzweig, and R. Roeder. 1996. The B-cell-specific transcription coactivator OCA-B/OBF-1/Bob-1 is essential for normal production of immunoglobulin isotypes. Nature. 383: 542-547.
72. Rothe, J., W. Lesslauer, H. Lötscher, Y. Lang, P. Koebel, F. Köntgen A. Althage, R. Zinkernagel, M. Steinmetz, and H. Bluethmann. 1993. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature. 364: 798-802.
73. Grilli, M., J.-S. Chiu, and M.J. Lenardo. 1993. NF-κB and Rel-participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143:1-62.
74. Lin, S.-C., and J. Stavnezer. 1996. Activation of NF-κB/Rel by CD40 engagement induces the mouse germ line immunoglobulin Cγ1 promoter. Mol. Cell. Biol. 16:4591-4603.
75. Berberich, I., G.L. Shu, and E.A. Clark. 1994. Cross-linking CD40 on B cells rapidly activates nuclear factor-κB. J. Immunol. 153:4357-4366.